All publications

Sort by: Date | Author | Title

Wegener, G., Harvey, B. H., Volke, V., Bonefeld, B., Müller, H. K., Overstreet, D. H. & Elfving, B. (2008). Stress associated changes in the nitric oxide signaling cascade in a genetic animal model of depression. Poster session presented at Psykiatriens 3. Forskningsdag, Risskov, Denmark.

Wegener, G., Volke, V. & Harvey, B. H. (2008). The Nitric Oxide pathway in anxiety and stress-related disorders. Abstract from 16th European Congress of Psychiatry (AEP), Nice, France.

Wegener, G. (2008). Early life adverse events: Inflammation and mediators. Abstract from World Congress of Psychiatry, Prague (World Psychiatric Association), Czech Republic.

Wegener, G., Finger, B. C., Slattery, D., Neumann, I. D. & Mathé, A. A. (2008). Neuropeptide S alters depression- and anxiety-like behaviours in the Flinders Sensitive Line rats, a genetic animal model of depression. Abstract from 47nd ACNP Annual Meeting, 2008, Arizona, United States.

Wegener, G., Harvey, B. H., Bonefeld, B., Müller, H. K., Volke, V., Overstreet, D. H. & Elfving, B. (2010). Increased stress-evoked nitric oxide signalling in the Flinders sensitive line (FSL) rat: a genetic animal model of depression. International Journal of Neuropsychopharmacology, 13, 461-473. https://doi.org/10.1017/S1461145709990241

Wegener, G., Finger, B. C., Slattery, D. A., Neumann, I. D. & Mathé, A. A. (2009). Neuropeptide S alters depression- and anxiety-like behaviors in the FSL/FRL rats, a genetic animal model of depression. European Neuropsychopharmacology.

Wegener, G. & Rosenberg, R. (2009). Stress-begreber i neuropsykiatri. In R. Rosenberg & P. Videbech (Eds.), Lærebog i Neuropsykiatri FADL's Forlag.

Wegener, G. (2009). 1. Scandinavian College of Neuropsychopharmacology (SCNP, http://scnp.dk).

Wegener, G. (2009). 1. Collegium Internationale Neuro-Psychopharmacologicum (CINP, http://cinp.org).

Wegener, G., Finger, C., Slattery, D., Neumann, D. & Mathé, A. A. (2009). Neuropeptide S alters depression- and anxiety-like behaviors in the Flinders Sensitive Line rats, a genetic animal model of depression: Poster. Scandinavian Neuropsychopharmacology, 30-30.

Wegener, G., Harvey, BH., Volke, V., Bonefeld, B., Müller, H. K., Overstreet, DH. & Elfving, B. (2009). Stress associated changes in the nitric oxide signaling cascade in a genetic animal model of depression: Poster. Abstract from 9th World Congress of Biological Psychiatry 2009, Paris, France.

Wegener, G., Harvey, BH., Volke, V., Müller, H. K. & Elfving, B. (2009). Stress associated changes in the nitric oxide signaling cascade: relevance for affective psychopathology: Oral presentation. Abstract from 11th INTERNATIONAL CONGRESS ON • AMINO ACIDS, PEPTIDES AND PROTEINS, Wien, Austria.

Wegener, G. & Volke, V. (2010). Nitric Oxide Synthase Inhibitors as Antidepressants. Pharmaceuticals, 3(1), 273-299. https://doi.org/10.3390/ph3010273

Wegener, G., Volke, V., Harvey, B. & Elfving, B. (2010). The Nitric Oxide pathway in anxiety and stress-related disorders. Scandinavian Neuropsychopharmacology, 7-8.

Wegener, G., Finger, BC., Elfving, B., Keller, K., Singewald, N., Slattery, D., Neumann, ID. & Mathé, AA. (2010). Neuropeptide S alters anxiety, but not depression-like behaviors in the Flinders sensitive line rats, a genetic animal model of depression. Poster session presented at XXVII CINP Congress, Hong Kong.

Wegener, G., Harvey, BH., Abildgaard, A., Mors, O., Lund, S., Buttenschøn, H. N., Chen, F., Müller, H. K., Mathé, AA. & Elfving, B. (2010). Brain plasticity and behavior in depression: Gene and environment studies. International Journal of Neuropsychopharmacology, 16.

Wegener, G., Finger, BC., Elfving, B., Keller, K., Singewald, N., Slattery, D., Neumann, ID. & Mathé, AA. (2010). Neuropeptide S alters anxiety, but not depression-like behaviors in the flinders sensitive line rats, a genetic animal model of depression. International Journal of Neuropsychopharmacology, 121-121.

Wegener, G. (2010). Dyremodeller for psykiatriske sygdomme. BestPractice Nordic, 3(11), 38-42.

Wegener, G., Finger, B., Elfving, B., Slattery, D., Neumann, ID. & Mathé, A. (2011). Neuropeptide s alters anxiety-like, but not depression-like behavior in the flinders sensitive line rats, a genetic animal model of depression. Poster session presented at Mindlab AU Symposium, Aarhus, Denmark. http://www.mindlab.au.dk/medias/media106.jpg

Wegener, G., Finger, B. C., Elfving, B., Keller, K., Liebenberg, N., Fischer, C., Singewald, N., Slattery, D. A., Neumann, I. D. & Mathé, A. A. (2011). Neuropeptide S alters anxiety, but not depression-like behaviour in Flinders Sensitive Line rats: a genetic animal model of depression. International Journal of Neuropsychopharmacology, 1-13. https://doi.org/10.1017/S1461145711000678

Wegener, G. (2011). Book review: Biological psychiatry. Acta Psychiatrica Scandinavica, 124(162), 162-162.

Wegener, G. & Andreassen, O. A. (2011). Acta Neuropsychiatrica and Scandinavian College of Neuropsychopharmacology (SCNP). Acta Neuropsychiatrica, 23(5), 199-200. https://doi.org/10.1111/j.1601-5215.2011.00602.x

Wegener, G. (2011). Acta Neuropsychiatrica 4.0. Acta Neuropsychiatrica, 23(93), 93-93. https://doi.org/10.1111/j.1601-5215.2011.00567.x

Wegener, G. & Mathé, A. (2011). Nitric Oxide Signaling in Depression and Antidepressant Action. In F. López-Munoz & C. Àlamo (Eds.), Neurobiology of Depression (pp. 341-369). CRC Press, Taylor & Francis Group.

Wegener, G. (2011). The human illnesses. Neuropsychiatric disorders and the nature of the human brain. Acta Psychiatrica Scandinavica, 124, 498-498.

Wegener, G., Mathe, A. A. & Neumann, I. D. (2012). Selectively Bred Rodents as Models of Depression and Anxiety. Current topics in behavioral neurosciences, 12, 139-187 . https://doi.org/10.1007/7854_2011_192

Wegener, G. (2012). Welcome home. Acta Neuropsychiatrica, 24(6), 317. https://doi.org/10.1111/acn.12024

Wegener, G. (1996). Serotonergic (5-HT 1a) mechanisms modulate lithium-induced taste aversion in rats. Psykiatrisk Hospital i Risskov.

Wegener, G., Smith, D. F. & Rosenberg, R. (1997). 5-HT1A receptors in lithium-induced conditioned taste aversion. Psychopharmacology, 133(1), 51-4.

Wegener, G., Volke, V. & Rosenberg, R. (2000). Endogenous nitric oxide decreases hippocampal levels of serotonin and dopamine in vivo. British Journal of Pharmacology, 130(3), 575-80. https://doi.org/10.1038/sj.bjp.0703349

Wegener, G. & Rujescu, D. (2013). The current development of CNS drug research. International Journal of Neuropsychopharmacology, 1-7. https://doi.org/10.1017/S1461145713000345

Wegener, G. (2014). Let food be thy medicine, and medicine be thy food: Hippocrates revisited. Acta Neuropsychiatrica, 26(1), 1-3. https://doi.org/10.1017/neu.2014.3

Wegener, G. (2013). Acta Neuropsychiatrica: A new beginning. Acta Neuropsychiatrica, 25(1), 1. https://doi.org/10.1017/neu.2012.33

Wegener, C. & Wegener, G. (2016). Mirroring. In V. P. Glăveanu, L. Tanggaard & C. Wegener (Eds.), Creativity — A New Vocabulary (pp. 87-95). Palgrave Macmillan. https://doi.org/10.1057/9781137511805_11

Wegener, G. (2017). Acta Neuropsychiatrica and social media. Acta Neuropsychiatrica, 29(6), 323. https://doi.org/10.1017/neu.2017.30

Wegener, G. (2023). Navigating the complexity of COVID-19: a multifaceted examination. Acta Neuropsychiatrica, 35(5), 247. https://doi.org/10.1017/neu.2023.50

Wegener, G. (2024). Unravelling the complex tapestry of addiction: insights from recent research. Acta Neuropsychiatrica, 36(2), 65-66. https://doi.org/10.1017/neu.2024.8

Wegener, G. (2024). Advancing the understanding of cannabinoids in psychiatry. Acta Neuropsychiatrica, 36(5), 251-252. https://doi.org/10.1017/neu.2024.47

Wegener, G. (2011). Preclinical Studies of Serotonin and Nitric Oxide in Affective Disorders. Faculty of Health Sciences. University of Aarhus.

Weber, H., Kittel-Schneider, S., Gessner, A., Domschke, K., Neuner, M., Jacob, C. P., Buttenschøn, H. N., Boreatti-Hümmer, A., Volkert, J., Herterich, S., Baune, B. T., Gross-Lesch, S., Kopf, J., Kreiker, S., Nguyen, T. T., Weissflog, L., Arolt, V., Mors, O., Deckert, J. ... Reif, A. (2011). Cross-Disorder Analysis of Bipolar Risk Genes: Further Evidence of DGKH as a Risk Gene for Bipolar Disorder, but also Unipolar Depression and Adult ADHD. Neuropsychopharmacology, 36(10), 2076-2085. https://doi.org/10.1038/npp.2011.98

Wang, AG., Dahl, HA., Vang, M., Als, T. D., Ewald, H., Kruse, TA. & Mors, O. (2006). Genetics of panic disorder on the Faroe Islands: a replication study of chromosome 9 and panic disorder. Psychiatr Genet, 16(3), 99-104.

Wang, W., Li, C., Nejsum, L. N., Li, H., Kim, S. W., Kwon, T.-H., Jonassen, T. E. N., Knepper, M. A., Frøkiaer, J., Thomsen, K. & Nielsen, S. (2006). Biphasic effects of ANP infusion in conscious, euvolumic rats: roles of AQP2 and ENaC trafficking. American Journal of Physiology: Renal Physiology, 290(2), F530-41. https://doi.org/10.1152/ajprenal.00070.2005

Wang, G., Thomsen, K. & Frøkiær, J. (2013). Renal responses to acute volume expansion in spontaneously hypertensive rats is related to the baseline sodium excretion. Scandinavian Journal of Clinical and Laboratory Investigation. Supplement, 73(7), 529-37. https://doi.org/10.3109/00365513.2013.803232

Wang, X., Walker, A., Revez, J. A., Ni, G., Adams, M. J., McIntosh, A. M. & Major Depressive Disorder Working Group of the Psychiatric Genomics Consortium (2023). Polygenic risk prediction: why and when out-of-sample prediction R² can exceed SNP-based heritability. American Journal of Human Genetics, 110(7), 1207-1215. https://doi.org/10.1016/j.ajhg.2023.06.006

Wang, Q., Liao, J., Hair, K., Bannach-Brown, A., Bahor, Z., Currie, G. L., McCann, S. K., Howells, D. W., Sena, E. S. & Macleod, M. R. (2018). Estimating the statistical performance of different approaches to meta-analysis of data from animal studies in identifying the impact of aspects of study design. http://biorxiv.org/content/early/2018/01/30/256776.abstract

Wami, E. C. & Sinning, S. (2011). Molekylære determinanter for ecstasy analogers selektivitet. Poster session presented at Psykiatriens 6. Forskningsdag, Risskov, Denmark.

Wami, E. C. & Sinning, S. (2011). Molecular determinants for ecstasy analogue selectivity. Poster session presented at SFB 35 – Symposium: Transmembrane Transporters in Health and Disease 2011, Vienna, Austria, Wien, Austria.

Waller, J. A., Nygaard, S. H., Li, Y., du Jardin, K. G., Tamm, J. A., Abdourahman, A., Elfving, B., Pehrson, A. L., Sánchez, C. & Wernersson, R. (2017). Neuroplasticity pathways and protein-interaction networks are modulated by vortioxetine in rodents. BMC Neuroscience, 18(1), 56. Article 56. https://doi.org/10.1186/s12868-017-0376-x

Volke, V., Wegener, G. & Vasar, E. (2003). Augmentation of the NO-cGMP cascade induces anxiogenic-like effect in mice. J Physiol Pharmacol., 54(4), 653-660.

Volke, A., Wegener, G., Vasar, E. & Volke, V. (2006). High-performance liquid chromatography method with radiochemical detection for measurement of nitric oxide synthase, arginase, and arginine decarboxylase activities. Methods and Findings in Experimental and Clinical Pharmacology, 28(1), 3-6. https://doi.org/10.1358/mf.2006.28.1.962769

Displaying results 51 to 100 out of 2475

Revised 11.09.2025

Karen Jul Madsen